William C Bertrand Jr's Net Worth
$7.01 Million
Who is William C Bertrand Jr?
William C Bertrand Jr has an estimated net worth of $7.01 Million. This is based on reported shares across multiple companies, which include Adaptimmune Therapeutics PLC, ARDELYX, INC., INFINITY PHARMACEUTICALS, INC., SANTARUS INC, SALIX PHARMACEUTICALS LTD, and MEDIMMUNE INC /DE.
SEC CIK
William C Bertrand Jr's CIK is 0001291937
Past Insider Trading and Trends
2020 was William C Bertrand Jr's most active year for acquiring shares with 6 total transactions. William C Bertrand Jr's most active month to acquire stocks was the month of May. 2007 was William C Bertrand Jr's most active year for disposing of shares, totalling 10 transactions. William C Bertrand Jr's most active month to dispose stocks was the month of December. 2020 saw William C Bertrand Jr paying a total of $250,079.10 for 1,791,663 shares, this is the most they've acquired in one year. In 2015 William C Bertrand Jr cashed out on 31,258 shares for a total of $5,407,634.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.09
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -40.26% | -23.59K |
$0.71 | -$16,423.08 | 35.01K |
Jan 16 - Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
| -39.77% | -9.23K |
$0.85 | -$7,812.73 | 13.98K |
Jan 11 - Jan 12
| |||
Form 4
| -37.94% | -4.44K |
$1.86 | -$8,249.52 | 7.26K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| -37.99% | -8.82K |
$1.73 | -$15,196.89 | 14.39K |
Jan 11 - Jan 12
| |||
Form 4
| -38.27% | -3.58K |
$1.69 | -$6,071.30 | 5.78K |
Jan 4
| |||
Form 4
| -37.32% | -4.37K |
$3.19 | -$13,941.78 | 7.34K |
Jan 18
| |||
Form 4
| -37.34% | -6.02K |
$3.55 | -$21,375.90 | 10.1K |
Jan 11 - Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
| -37.27% | -3.49K |
$4.06 | -$14,184.06 | 5.87K |
Jan 4
| |||
Form 4
| -37.38% | -4.38K |
$4.26 | -$18,658.94 | 7.33K |
Jul 2
| |||
Form 4
| -37.22% | -2.23K |
$6.15 | -$13,744.01 | 3.77K |
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| -37.37% | -3.50K |
$5.33 | -$18,642.32 | 5.86K |
Jan 4
| |||
Form 4
| +266.04% | 207K |
$0.69 | $143,823.60 | 284.81K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
| -39.94% | -2.40K |
$5.13 | -$12,307.88 | 3.6K |
Jan 14
| |||
Form 4
| -39.85% | -3.73K |
$1.20 | -$4,477.20 | 5.63K |
Jan 6
| |||
Form 4
| -37.84% | -2.27K |
$5.37 | -$12,193.91 | 3.73K |
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARDELYX, INC. (ARDX) Snapshot price: $5.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.04% | 11.02K |
—
|
—
| 229.77K |
Jun 14
| |||
Form 4
| +8.20% | 16.58K |
—
|
—
| 218.74K |
Jun 15
| |||
Form 4
| +141.97% | 118.61K |
—
|
—
| 202.16K |
Jun 15
| |||
Form 4
| +11.91% | 8.89K |
—
|
—
| 83.55K |
Jun 16
| |||
Form 4
| +25.14% | 15K |
$7.08 | $106,255.50 | 74.66K |
Dec 14
| |||
Form 4
| +14.43% | 7.52K |
—
|
—
| 59.66K |
Jun 9
| |||
Form 4
| +53.85% | 18.25K |
—
|
—
| 52.13K |
Jun 13
| |||
Form 4
| +57.75% | 12.41K |
—
|
—
| 33.89K |
Jun 13
| |||
Form 4
| +117.99% | 11.63K |
—
|
—
| 21.48K |
Jun 7
| |||
Form 4
| +97.08% | 4.85K |
—
|
—
| 9.85K |
Jun 2
| |||
Form 4
|
∞
| 5K |
$20.00 | $100,000.00 | 5K |
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.000001
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SANTARUS INC No price found
Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SALIX PHARMACEUTICALS LTD No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -31.26K |
$173.00 | -$5,407,634.00 |
0
|
Apr 1
| |||
Form 4
| +10.04% | 2.85K |
—
|
—
| 31.26K |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 14.43K |
—
|
—
| 14.43K |
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |